iconEarnings Announcement Before Market Open

Eli Lilly and Co LLY:NYSE

RT Quote | NYSE | USD
Last | 08/02/21 EDT
246.60quote price arrow up+3.10 (+1.27%)
Volume
1,733,449
52 week range
129.21 - 248.40

...

Loading . . .
  • Open245.73
  • Day High247.88
  • Day Low244.25
  • Prev Close246.60
  • 52 Week High248.40
  • 52 Week High Date07/28/21
  • 52 Week Low129.21
  • 52 Week Low Date10/30/20

Key Stats

  • Market Cap236.497B
  • Shares Out959.03M
  • 10 Day Average Volume2.07M
  • Dividend3.40
  • Dividend Yield1.38%
  • Beta0.26
  • YTD % Change46.06

KEY STATS

  • Open245.73
  • Day High247.88
  • Day Low244.25
  • Prev Close246.60
  • 52 Week High248.40
  • 52 Week High Date07/28/21
  • 52 Week Low129.21
  • 52 Week Low Date10/30/20
  • Market Cap236.497B
  • Shares Out959.03M
  • 10 Day Average Volume2.07M
  • Dividend3.40
  • Dividend Yield1.38%
  • Beta0.26
  • YTD % Change46.06

RATIOS/PROFITABILITY

  • EPS (TTM)6.68
  • P/E (TTM)36.93
  • Fwd P/E (NTM)31.32
  • EBITDA (MRQ)8.213B
  • ROE (MRQ)122.12%
  • Revenue (MRQ)25.486B
  • Gross Margin (MRQ)75.88%
  • Net Margin (MRQ)23.91%
  • Debt To Equity (MRQ)234.89%

EVENTS

  • Earnings Date08/03/2021
  • Ex Div Date08/12/2021
  • Div Amount0.85
  • Split Date-
  • Split Factor-

Content From Our Affiliates

Profile

MORE
Eli Lilly and Company is a drug manufacturing company. The Company discover, develop, manufacture, and market products in a human pharmaceutical product segment. The Company’s products include Diabetes and other endocrinology products, including Baqsimi, Basaglar, Forteo, Humalog, Humatrope, Humulin, Jardiance, Trajenta and Trulicity. Its Immunology products include Olumiant and Taltz. Its Neuroscience products include Cymbalta, Emgality, Reyvow, Strattera and Zyprexa. Its...
David Ricks
Chairman
Anat Ashkenazi
Chief Financial Officer
Address
Lilly Corporate Ctr
Drop Code 1094, Lilly Corporate Ctr
Indianapolis, IN
46285-0001
United States

Top Peers

SYMBOLLASTCHG%CHG
AZN
AstraZeneca PLC
57.38+0.14+0.24%
AMGN
Amgen Inc
239.79-1.75-0.72%
PFE
Pfizer Inc
43.96+1.15+2.69%
NVS
Novartis AG
92.27UNCHUNCH
MRK
Merck & Co Inc
76.18-0.69-0.90%